FY2026 EPS Estimates for Palomar Decreased by Zacks Research

Palomar Holdings, Inc. (NASDAQ:PLMR) – Zacks Research lowered their FY2026 earnings per share estimates for Palomar in a research note issued on Thursday, June 25th. Zacks Research analyst Team now expects that the company will earn $8.80 per share for the year, down from their previous estimate of $9.87. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $8.96 per share. Zacks Research also issued estimates for Palomar’s Q4 2026 earnings at $2.50 EPS, Q2 2027 earnings at $1.99 EPS, Q3 2027 earnings at $2.91 EPS, Q4 2027 earnings at $2.66 EPS, FY2027 earnings at $9.84 EPS and Q1 2028 earnings at $3.06 EPS.

Palomar (NASDAQ:PLMR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.14. The firm had revenue of $278.94 million for the quarter, compared to analyst estimates of $557.79 million. Palomar had a net margin of 20.11% and a return on equity of 22.62%. Palomar’s revenue was up 59.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.87 EPS.

Several other equities research analysts also recently issued reports on the company. JPMorgan Chase & Co. cut their price objective on Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a report on Tuesday, May 26th. Piper Sandler dropped their target price on Palomar from $151.00 to $132.00 and set an “overweight” rating for the company in a research report on Monday, May 11th. Weiss Ratings raised Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, June 18th. Keefe, Bruyette & Woods cut their price target on shares of Palomar from $186.00 to $159.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Finally, Wall Street Zen cut shares of Palomar from a “buy” rating to a “hold” rating in a research report on Sunday, March 1st. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $147.75.

Palomar Stock Performance

NASDAQ:PLMR opened at $126.32 on Monday. Palomar has a fifty-two week low of $100.81 and a fifty-two week high of $156.55. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.49 and a current ratio of 0.49. The company has a 50 day moving average price of $115.45 and a 200 day moving average price of $122.45. The stock has a market capitalization of $3.35 billion, a P/E ratio of 17.59 and a beta of 0.44.

Institutional Investors Weigh In On Palomar

Several hedge funds and other institutional investors have recently bought and sold shares of PLMR. Geneos Wealth Management Inc. purchased a new stake in Palomar in the fourth quarter valued at $32,000. Kestra Advisory Services LLC purchased a new position in shares of Palomar during the fourth quarter worth about $33,000. Rockefeller Capital Management L.P. increased its position in shares of Palomar by 81.5% during the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after purchasing an additional 132 shares in the last quarter. Clearstead Advisors LLC increased its position in shares of Palomar by 31.0% during the third quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock worth $46,000 after purchasing an additional 94 shares in the last quarter. Finally, Parallel Advisors LLC lifted its holdings in shares of Palomar by 638.3% in the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after purchasing an additional 383 shares during the last quarter. 90.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Palomar

In related news, CEO Mac Armstrong sold 3,500 shares of Palomar stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $112.96, for a total value of $395,360.00. Following the completion of the transaction, the chief executive officer owned 329,388 shares in the company, valued at $37,207,668.48. The trade was a 1.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 1,937 shares of the business’s stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $128.62, for a total transaction of $249,136.94. Following the transaction, the president owned 65,919 shares of the company’s stock, valued at $8,478,501.78. This trade represents a 2.85% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 18,634 shares of company stock worth $2,291,441. 3.70% of the stock is owned by corporate insiders.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.